Do Not Do Recommendation
Calcium channel blockers are not recommended for the treatment of cor pulmonale.
Do Not Do Recommendation Details
- Calcium channel blockers are not recommended for the treatment of cor pulmonale.
- calcium channel blockers
Source guidance details
- Chronic obstructive pulmonary disease (update) (CG101)
- Published date:
- June 2010
- Paragraph number:
- Page number:
View all NICE do not do from this Guidance
- In most patients routine spirometric reversibility testing is not necessary as a part of the diagnostic process or to plan initial therapy with bronchodilators or corticosteroids.
- Oral corticosteroid reversibility tests do not predict response to inhaled corticosteroid therapy and should not be used to identify which patients should be prescribed inhaled corticosteroids.
- Do not routinely use mucolytic drugs to prevent exacerbations in people with stable chronic obstructive pulmonary disease (COPD).
- Treatment with alpha-tocopherol and beta-carotene supplements, alone or in combination, is not recommended.
- Anti-tussive therapy should not be used in the management of stable chronic obstructive pulmonary disease (COPD).
- Ambulatory oxygen therapy is not recommended in chronic obstructive pulmonary disease (COPD) if partial pressure of oxygen in arterial blood (PaO2) is greater than 7.3 kilopascal (kPa) and there is no exercise desaturation.
- Angiotensin-converting enzyme inhibitors are not recommended for the treatment of cor pulmonale.
- Alpha-1 antitrypsin replacement therapy is not recommended for patients with alpha-1 antitrypsin deficiency.
- In patients who have their exacerbation managed in primary care, sending sputum samples for culture is not recommended in routine practice.
- A course of corticosteroid treatment longer than 14 days is not recommended as there is no advantage in prolonged therapy.
- Patients with exacerbations without more purulent sputum do not need antibiotic therapy unless there is consolidation on a chest radiograph or clinical signs of pneumonia.
- Daily monitoring of peak expiratory flow (PEF) or forced expiratory volume in 1 second (FEV1) should not be performed routinely to monitor recovery from an exacerbation because the magnitude of changes is small compared with the variability of the measurement.
- Alpha-blockers are not recommended for the treatment of cor pulmonale.
- Digoxin (unless there is atrial fibrillation) is not recommended for the treatment of cor pulmonale.